Trademark: 90700794
Status Date
Tuesday, May 23, 2023
Filing Date
Monday, May 10, 2021
Published for Opposition
Tuesday, March 1, 2022
Abandoned Date
Thursday, May 4, 2023
44 Medical treatment of fibromyalgia, pain, interstitial cystitis, chronic fatigue syndrome, immune system deficiencies, immune system dysfunction; Medical diagnosis and treatment of fibromyalgia, chronic pain, interstitial cystitis, immune system deficiencies, immune system dysfunction; Medical services, namely, medical testing services relating to the diagnosis and treatment of fibromyalgia, chronic pain, interstitial cystitis, immune system deficiencies, immune system dysfunction
May 24, 2023
Abandonment Notice E-Mailed - Failure To Respond
May 23, 2023
Abandonment Notice Mailed - Failure To Respond
May 23, 2023
Abandonment - Failure To Respond Or Late Response
Feb 2, 2023
Notification Of Non-Final Action E-Mailed
Feb 2, 2023
Non-Final Action E-Mailed
Feb 2, 2023
Su - Non-Final Action - Written
Jan 12, 2023
Statement Of Use Processing Complete
Apr 27, 2022
Use Amendment Filed
May 7, 2022
Case Assigned To Intent To Use Paralegal
Apr 27, 2022
Teas Statement Of Use Received
Apr 26, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 1, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 1, 2022
Published For Opposition
Feb 9, 2022
Notification Of Notice Of Publication E-Mailed
Jan 21, 2022
Approved For Pub - Principal Register
Jan 20, 2022
Examiner's Amendment Entered
Jan 20, 2022
Notification Of Examiners Amendment E-Mailed
Jan 20, 2022
Examiners Amendment E-Mailed
Jan 20, 2022
Examiners Amendment -Written
Jan 13, 2022
Assigned To Examiner
Aug 10, 2021
New Application Office Supplied Data Entered
May 13, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
